They showed that 250 μg/mouse of an anti-murine TIM-3 antibody given at day 7, 11, and 15 post intracranial implantation of GL261 mouse glioma cells had no significant effect to mouse median or overall survival (OS) compared to control treated mice. This evidence concerns the gene HAVCR2 and glioma.